Shockwave Medical to Report Second Quarter 2021 Financial Results on August 9, 2021

Rhea-AI Summary

Shockwave Medical (Nasdaq: SWAV) will report its Q2 2021 financial results on August 9, 2021, before market open. The company is known for its innovative Intravascular Lithotripsy (IVL) technology aimed at treating calcified cardiovascular disease. A conference call for investors will take place at 5:30 a.m. PT / 8:30 a.m. ET. Domestic callers can dial (866) 795-9106, while international callers can reach (470) 495-9173, with the conference ID: 1687208. The call will also be available as a webcast for greater accessibility.

Positive

• Anticipation for Q2 2021 financial results may imply strong market interest.
• Innovative technology (IVL) positions the company favorably in the cardiovascular treatment sector.

Negative

• None.

SANTA CLARA, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced it will report financial results for the second quarter 2021 before market open on Monday, August 9, 2021. Company management will host a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.  

Investors interested in listening to the conference call may do so by dialing (866) 795-9106 for domestic callers or (470) 495-9173 for international callers, using conference ID: 1687208. A live and archived webcast of the event will be available at https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Rob Fletcher
rfletcher@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com

FAQ

When will Shockwave Medical report its Q2 2021 financial results?

Shockwave Medical will report its Q2 2021 financial results on August 9, 2021, before market open.

What is Intravascular Lithotripsy?

Intravascular Lithotripsy (IVL) is a technology developed by Shockwave Medical aimed at treating complex calcified cardiovascular disease.

How can I listen to the Shockwave Medical conference call?

Investors can listen to the conference call by dialing (866) 795-9106 for domestic calls or (470) 495-9173 for international calls, using conference ID: 1687208.

What time is the Shockwave Medical conference call scheduled?

The conference call is scheduled for 5:30 a.m. PT / 8:30 a.m. ET on August 9, 2021.